FI955587A7 - Kemialliset yhdisteet - Google Patents

Kemialliset yhdisteet Download PDF

Info

Publication number
FI955587A7
FI955587A7 FI955587A FI955587A FI955587A7 FI 955587 A7 FI955587 A7 FI 955587A7 FI 955587 A FI955587 A FI 955587A FI 955587 A FI955587 A FI 955587A FI 955587 A7 FI955587 A7 FI 955587A7
Authority
FI
Finland
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Application number
FI955587A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI955587A0 (fi
Inventor
Peter Clive Cherry
John Derek Cocker
Andrew David Searle
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI955587A0 publication Critical patent/FI955587A0/fi
Publication of FI955587A7 publication Critical patent/FI955587A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI955587A 1993-05-21 1995-11-20 Kemialliset yhdisteet FI955587A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939310635A GB9310635D0 (en) 1993-05-21 1993-05-21 Chemical compounds
PCT/EP1994/001613 WO1994027989A1 (en) 1993-05-21 1994-05-19 Carbazole derivatives with 17,20-lyase-inhibiting activity

Publications (2)

Publication Number Publication Date
FI955587A0 FI955587A0 (fi) 1995-11-20
FI955587A7 true FI955587A7 (fi) 1995-11-20

Family

ID=10736007

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955587A FI955587A7 (fi) 1993-05-21 1995-11-20 Kemialliset yhdisteet

Country Status (19)

Country Link
EP (1) EP0699196A1 (online.php)
JP (1) JPH08510455A (online.php)
CN (1) CN1126473A (online.php)
AU (1) AU6928794A (online.php)
BG (1) BG100154A (online.php)
CA (1) CA2162921A1 (online.php)
CZ (1) CZ305195A3 (online.php)
FI (1) FI955587A7 (online.php)
GB (1) GB9310635D0 (online.php)
HU (1) HUT73790A (online.php)
IL (1) IL109703A0 (online.php)
NO (1) NO954681L (online.php)
OA (1) OA10195A (online.php)
PE (1) PE31195A1 (online.php)
PL (1) PL311702A1 (online.php)
SK (1) SK142495A3 (online.php)
TW (1) TW279866B (online.php)
WO (1) WO1994027989A1 (online.php)
ZA (1) ZA943494B (online.php)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1131944A (zh) * 1993-09-30 1996-09-25 山之内制药株式会社 唑类衍生物和它的药物组合物
WO1996014090A1 (en) * 1994-11-07 1996-05-17 Janssen Pharmaceutica N.V. Compositions comprising carbazoles and cyclodextrins
PL322028A1 (en) * 1995-03-01 1998-01-05 Yamanouchi Pharma Co Ltd Derivatives of imidazoles and pharmaceutic composition containing them
EP0974584B1 (en) * 1997-02-21 2003-01-15 Takeda Chemical Industries, Ltd. Fused ring compounds, process for producing the same and use thereof
EP1334106B1 (en) 2000-11-17 2006-05-24 Takeda Pharmaceutical Company Limited Imidazole derivatives, production method thereof and use thereof
ATE502030T1 (de) 2000-11-20 2011-04-15 Takeda Pharmaceutical Imidazolderivate, verfahren zu deren herstellung und deren verwendung
WO2002046186A1 (en) 2000-12-08 2002-06-13 Takeda Chemical Industries, Ltd. Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
MX2007015905A (es) * 2005-06-24 2008-03-06 Lilly Co Eli Derivados de tetrahidrocarbazol utiles como moduladores de receptor de androgeno (sarm).
GB0525323D0 (en) 2005-12-13 2006-01-18 Sterix Ltd Compound
US8093279B2 (en) 2005-12-13 2012-01-10 Gillian Reed, legal representative Compound
CN100586932C (zh) * 2007-01-26 2010-02-03 中国医学科学院医药生物技术研究所 抗肿瘤化合物及其制备方法
MA33451B1 (fr) 2009-06-26 2012-07-03 Novartis Ag Dérivés d'imidazolidin-2-one 1,3-disubstitués en tant qu'inhibiteurs de cyp 17
CA2788907A1 (en) * 2010-02-04 2011-08-11 Radius Health, Inc. Selective androgen receptor modulators
PT2568806T (pt) 2010-05-12 2016-08-05 Radius Health Inc Regimes terapêuticos
US9132105B2 (en) 2010-08-04 2015-09-15 Pellficure Pharmaceuticals, Inc. Treatment of prostate carcinoma
JP2013537210A (ja) 2010-09-16 2013-09-30 ノバルティス アーゲー 17α−ヒドロキシラーゼ/C17,20−リアーゼ阻害剤
ES2550319T3 (es) 2010-09-28 2015-11-06 Radius Health, Inc Moduladores selectivos del receptor de andrógenos
EA023064B1 (ru) 2011-04-28 2016-04-29 Новартис Аг ИНГИБИТОРЫ 17α-ГИДРОКСИЛАЗЫ/C-ЛИАЗЫ
US9492460B2 (en) * 2013-02-27 2016-11-15 Bristol-Myers Squibb Company Carbazole compounds useful as bromodomain inhibitors
AU2014241816B9 (en) 2013-03-14 2019-02-14 Pellficure Pharmaceuticals Inc. Novel therapy for prostate carcinoma
RS67458B1 (sr) 2014-03-28 2025-12-31 Univ Duke Lečenje kancera dojke pozitivnog na receptor estrogena upotrebom selektivnih modulatora receptora estrogena
US9421264B2 (en) 2014-03-28 2016-08-23 Duke University Method of treating cancer using selective estrogen receptor modulators
CA2960750A1 (en) 2014-09-12 2016-03-17 Pellficure Pharmaceuticals, Inc. Compositions and methods for treatment of prostate carcinoma
RS63311B1 (sr) 2016-06-22 2022-07-29 Ellipses Pharma Ltd Ar+ metode lečenja raka dojke
WO2018080933A1 (en) 2016-10-24 2018-05-03 Pellficure Pharmaceuticals Inc. Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione
KR102881465B1 (ko) 2017-01-05 2025-11-04 래디어스 파마슈티컬스, 인코포레이티드 Rad1901-2hcl의 다형 형태

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS229934B2 (en) * 1981-07-07 1984-07-16 Pfizer Production method subst.indolylacryte acid derivative
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
EP0699196A1 (en) 1996-03-06
OA10195A (en) 1996-12-18
JPH08510455A (ja) 1996-11-05
NO954681D0 (no) 1995-11-20
IL109703A0 (en) 1994-08-26
PE31195A1 (es) 1995-10-18
CA2162921A1 (en) 1994-12-08
SK142495A3 (en) 1996-06-05
CN1126473A (zh) 1996-07-10
FI955587A0 (fi) 1995-11-20
PL311702A1 (en) 1996-03-04
CZ305195A3 (en) 1996-06-12
WO1994027989A1 (en) 1994-12-08
HU9503321D0 (en) 1996-01-29
BG100154A (en) 1996-07-31
GB9310635D0 (en) 1993-07-07
TW279866B (online.php) 1996-07-01
HUT73790A (en) 1996-09-30
ZA943494B (en) 1995-01-23
AU6928794A (en) 1994-12-20
NO954681L (no) 1995-11-20

Similar Documents

Publication Publication Date Title
FI954327L (fi) Atsasykloheksapeptidiyhdisteitä
FI922424A7 (fi) Kemiallisia yhdisteitä
FI955587A0 (fi) Kemialliset yhdisteet
FI944078A7 (fi) Kemiallisia yhdisteitä
FI970907L (fi) Pyridatsinokinoliiniyhdisteitä
MX9101375A (es) Compuestos quimicos
BR1101108A (pt) Composto
FI941574L (fi) Kemiallisia yhdisteitä
FI972683L (fi) Kemiallisia yhdisteitä
FI911286A7 (fi) Kemialliset yhdisteet
FI954016A7 (fi) Uudet yhdisteet
DK72693D0 (da) Compounds
FI922423A7 (fi) Kemiallisia yhdisteitä
FI945907A0 (fi) Kemiallisia yhdisteitä
DK124393D0 (da) Compounds
DE59409946D1 (de) Antidröhnmassen.
FI954017A7 (fi) Uudet yhdisteet
NO962264D0 (no) Kjemiske forbindelser
MX9205851A (es) Compuestos quimicos
FI954399L (fi) Kemiallinen prosessi
DK244090D0 (da) Kemiske forbindelser
ITRM940566A0 (it) Composti organici
FI954400L (fi) Kemiallinen prosessi
DK150591D0 (da) Kemisk forbindelse
FI943637L (fi) Aryylialkoksifenoksi-imidatsoliiniyhdisteitä

Legal Events

Date Code Title Description
FD Application lapsed